Japanese life and non-life insurers' underwriting fundamentals are likely to remain healthy overall in 2024, mainly because of waning effects from claims arising from the Covid-19 pandemic, Fitch Ratings says. As a result, Fitch has a neutral sector outlook for Japanese insurers.